News

For patients living with memory disorders, life requires “adjusting to the new normal,” sometimes even on a daily basis.

In a continuous effort to evaluate curative therapies for amyotrophic lateral sclerosis (ALS), Duke will soon be conducting a new pilot study that administers curcumin—an ingredient found in turmer

Tom Dreyer, PA-C, first became interested in neurology as a high school student. This fascination grew after a neurology elective during his training as a physician assistant.

Neurological conditions do not occur in a vacuum. A patient hospitalized for a heart attack may suddenly have a stroke. A patient with a metastatic tumor could suddenly start having a seizure.

Dozens of neurology-related (or neuro-adjacent) events are planned at Duke for the first few months of 2020, within our Department as well as those of our colleagues.

This week’s “Spotlight” interview shines on Alexa Putka, an undergraduate researcher in the lab of Audrey Dickey, PhD.

Even as our understanding of how factors like genetics, metabolomics, and the environment contribute to Parkinson’s disease has rapidly advanced over the past 20 years, there are still no disea

New research indicates intravenous tissue-type plasminogen activator (IV tPA) only increases the risk for brain hemorrhage in patients with previous stroke if the prior occurred within the past two

A peripherally acting opioid with multifunctional agonistic properties has shown to provide peripheral pain relief in morphine-tolerant mice with minimal side effects associated with classic opioid

Members of the Duke Department of Neurology contributed to nine studies in peer-reviewed journals published in December 2019.